A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. - Bowden,R.; Chadrasekar,P.; White,M.H.; Li,X.; Pietrelli,L.; Gurwith,M.; Burik,J.A van.; Laverdiere,M.; Safrin,S.; Wingard,J.R. (Clin Infect Dis, 2002)